The Chemours Company (CC) SEC Filings & Earnings Calls
EquiReason read 17 The Chemours Company SEC filings in the last 12 months. Latest: 8-K on 2026-09-10 — Chemours, DuPont, and Corteva enter $455M settlement agreement with North Carolina and 11 local entities over PFAS emissions from Fayetteville Works facility. Payment over 15 years.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 1.9B
- P/E TTM
- —
- Dividend yield
- 2.7%
- 52-week
- —
- Next earnings
- 17 Feb, in 116 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
10 Sep 20268-K · 1.01, 7.01Chemours, DuPont, and Corteva enter $455M settlement agreement with North Carolina and 11 local entities over PFAS emissions from Fayetteville Works facility. Payment over 15 years; Chemours responsible for 50%. Settlement resolves all PFASopen
Figures in the filing · each found in the filing text
| settlement amount · over 15 years | $455M | |
| Chemours share of settlement · 2026-09-09 | 50.0% | |
| net present value of settlement for MOU cap · 2026-09-09 | $210M |
Risks flagged
Significant PFAS-related settlement liability of $455M over 15 years, with Chemours responsible for 50%. Ongoing litigation risk for other PFAS claims, including personal injury and natural resource damages.
“Settlement Agreement includes an aggregate payment to the Claimants in the amount of $455 million ... payable over a 15-year period”
5 Aug 202610-QEnvironmental Remediation Reserve - Washington Works $174M; Environmental Remediation Reserve - Washington Works (prior period) $24M; Environmental Remediation Reserve - Remedial Actions $43Mopen
Figures in the filing · each found in the filing text
| Environmental Remediation Reserve - Washington Works · Washington Works · Q2-2026 | $174M | |
| Environmental Remediation Reserve - Washington Works (prior period) · Washington Works · FY2025 | $24M | |
| Environmental Remediation Reserve - Remedial Actions · Washington Works · Q2-2026 | $43M | |
| Environmental Remediation Reserve - Remedial Actions (prior period) · Washington Works · FY2025 | $24M | |
| Off-site Drinking Water Program Reserve Increase · Washington Works · Q2-2026 | $113M | |
| Accrued Litigation - Washington Works (prior period) · Washington Works · FY2025 | $16M | |
| NJ DEP RFS Request · Chambers Works · Q2-2026 | $943M | |
| Avoided CO2-equivalent Emissions (cumulative) · Thermal & Specialized Solutions · FY2025 | 350,000,000 |
Risks flagged
PFAS Environmental Liability
“the Company recognized an increase to its environmental remediation reserve for the off-site drinking water program at Washington Works of $113 million in the second quarter of 2026.” · word for word
PFAS Regulatory Risk
“The estimated earliest entry into force of restrictions is 2027, contingent upon timely completion of the remaining steps in the EU REACH restriction process.” · word for word
PFAS Litigation Risk
“NJ DEP filed a motion for a preliminary injunction requiring EID and us to establish a remediation funding source (RFS) in the amount of $943 million for Chambers Works, the majority of which is for non-PFAS remediation items.” · word for word
US PFAS MCL Uncertainty
“EPA announced that it intends to retain the MCLs for PFOS and PFOA, with rulemaking for additional time for compliance, and to rescind the other MCLs and hazard index.” · word for word
EU F-Gas Regulation Uncertainty
“we encountered uncertainty on how to report due to impacts from the implementation of the new regulation in the reporting portal as well as technical challenges associated therewith.” · word for word
4 Aug 20268-K · 2.02Q2 2026 net sales flat at $1.6B, net loss $274M vs $380M prior year, adjusted EBITDA $247M vs $260M prior year, free cash flow improved 128%.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q2-2026 | $1.59B | -1% y/y |
| Net Loss attributable to Chemours · Q2-2026 | $-274M | -28% y/y |
| Adjusted EBITDA · Q2-2026 | $247M | -5% y/y |
| Adjusted Net Income · Q2-2026 | $64M | -30% y/y |
| Adjusted EPS · Q2-2026 | $0.42 | -31% y/y |
| Free Cash Flow Conversion · Q2-2026 | 46.0% | |
| Net Leverage · Q2-2026 | $4.40 | |
| TSS Net Sales · Thermal & Specialized Solutions · Q2-2026 | $591M | -1% y/y |
| TSS Adjusted EBITDA · Thermal & Specialized Solutions · Q2-2026 | $213M | +3% y/y |
| TSS Adjusted EBITDA Margin · Thermal & Specialized Solutions · Q2-2026 | 36.0% |
Risks flagged
Legacy litigation and environmental liabilities continue to impact net income with significant reserves.
“Net Loss attributable to Chemours of $274 million includes impact of legal and environmental reserves related to EPA and WVDEP settlement and ongoing litigation.”
Volume decline in TSS aftermarket refrigerants due to prior-year channel fill normalization.
“Volume decline primarily driven by lower TSS Opteon blends aftermarket refrigerant sales, compared with elevated demand in Q2 2025 driven by initial aftermarket channel fill.”
Washington Works site outage impacted APM costs and margins.
“Adjusted EBITDA decrease driven by anticipated higher APM costs associated with the recently resolved outage at the Washington Works site.”
24 Jun 20268-K · 1.01, 7.01Chemours agrees to Consent Decree with EPA and WVDEP resolving PFAS emissions claims; $22.5M civil penalty, $90M mitigation projects over 15 years, and expanded drinking water programs.open
Figures in the filing · each found in the filing text
| Civil Penalty · 2026 | $23M | |
| Mitigation Projects Funding · 15 years | $90M | |
| West Virginia Rivers Coalition Settlement · 2024 | $1M |
Risks flagged
PFAS regulatory and litigation risk: Consent Decree imposes $112.5M total obligations, plus ongoing remediation and litigation costs.
“Chemours has agreed to pay a civil penalty in the amount of $22.5 million... over the next 15 years, Chemours will dedicate $90 million to the funding of additional mitigation projects... expansion of off-site drinking water programs will result in an increase to its existing environmental reserves.” · word for word
Court approval and appeal risk: Consent Decree subject to notice, comment, and court approval; appeals could delay or modify terms.
“The terms of the Settlement remain subject to notice and comment in accordance with applicable federal regulations, as well as court approval.” · word for word
Ongoing PFAS litigation: personal injury, natural resource damages, and other claims not resolved by this settlement.
“the outcome of any pending or future litigation related to PFAS or PFOA, including personal injury claims and natural resource damages claims” · word for word
Cost-sharing arrangement risk: performance of cost-sharing with Corteva and DuPont may not fully cover liabilities.
“the expected performance and impact of the cost-sharing arrangements by and between Chemours, Corteva, Inc. and DuPont de Nemours related to future eligible PFAS liabilities” · word for word
5 May 202610-QNet Sales $5.80B (+0% y/y); Net Loss $-386M; Adjusted EBITDA $742M (-3% y/y)open
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $5.80B | 0% y/y |
| Net Loss · FY2025 | $-386M | |
| Adjusted EBITDA · FY2025 | $742M | -3% y/y |
| Adjusted Net Income · FY2025 | $143M | |
| Operating Cash Flow · FY2025 | $264M | |
| Capital Expenditures · FY2025 | $213M | -41% y/y |
| TSS Net Sales · Thermal & Specialized Solutions · FY2025 | $2.10B | |
| TSS Adjusted EBITDA · Thermal & Specialized Solutions · FY2025 | $670M | +18% y/y |
| TT Net Sales · Titanium Technologies · FY2025 | $2.40B | -6% y/y |
| TT Adjusted EBITDA · Titanium Technologies · FY2025 | $145M | -52% y/y |
Risks flagged
PFAS Regulatory Risk
“The impacts of these various restrictions and regulatory measures in the EU as noted above, individually and in the aggregate, could lead to material adverse effects on our results of operations, financial condition, and cash flows.” · word for word
Litigation Liability Risk
“Litigation-related charges primarily includes $270 million related to the Company’s portion of Chemours, DuPont, Corteva, EID and the State of New Jersey’s settlement agreement reached in August 2025”
Environmental Remediation Cost Risk
“Environmental charges primarily includes changes in remediation reserves at the four sites covered by the New Jersey settlement agreement.”
5 May 20268-K · 2.02Net Loss attributable to Chemours $-29M (-480% y/y); Adjusted Net Income $8M (-58% y/y); Adjusted EBITDA $169M (+2% y/y); Guidance: Adjusted EBITDA $169M vs $166M YoY (+2%)earningsopen
Figures in the filing · each found in the filing text
| Net Loss attributable to Chemours · Total Chemours · Q1-2026 | $-29M | -480% y/y |
| Adjusted Net Income · Total Chemours · Q1-2026 | $8M | -58% y/y |
| Adjusted EBITDA · Total Chemours · Q1-2026 | $169M | +2% y/y |
| Kuan Yin Site Net Proceeds · Q1-2026 | $287M | |
| Debt Paydown · Q1-2026 | $140M | |
| TSS Net Sales · Thermal & Specialized Solutions · Q1-2026 | $568M | +22% y/y |
| TSS Adjusted EBITDA · Thermal & Specialized Solutions · Q1-2026 | $190M | +35% y/y |
| TSS Adjusted EBITDA Margin · Thermal & Specialized Solutions · Q1-2026 | 33.0% | |
| Opteon Refrigerants Net Sales · Thermal & Specialized Solutions - Opteon Refrigerants · Q1-2026 | $313M | +12% y/y |
| Freon Refrigerants Net Sales · Thermal & Specialized Solutions - Freon Refrigerants · Q1-2026 | $162M | +67% y/y |
Guidance
Adjusted EBITDA $169M vs $166M YoY (+2%)
Management reaffirms full-year growth guidance with positive tone, citing strong TSS performance and debt reduction, but acknowledges cyclical headwinds in TT and APM.
Risks flagged
Volume decline in TT and APM due to weak cyclical end markets and operational outage
“The decrease in volume was primarily driven by constraints in production due to an operational outage in APM and weaker cyclical end markets impacting both TT and APM” · word for word
Increased financing costs from recent debt offering impacting net income
“The larger first quarter Net Loss attributable to Chemours was driven by increased financing costs associated with a recent debt offering and higher Selling, General and Administrative costs.” · word for word
TT segment margin pressure: Adjusted EBITDA margin down 5 ppts to 3%
“TT Adjusted EBITDA Margin 3%, down 5 ppts”
12 Mar 20268-K · 1.01, 2.03, 8.01Chemours closed a $700M private offering of 7.875% Senior Notes due 2034, using proceeds to redeem existing notes due 2027 and 2028, refinancing debt.open
Figures in the filing · each found in the filing text
| Aggregate principal amount of new notes · 2026-03-12 | $700M | |
| Interest rate on new notes · 2026-03-12 | 7.9% | |
| Redeemed notes principal - 2028 · 2026-03-12 | $188M | |
| Redeemed notes principal - 2027 · 2026-03-12 | $500M |
Risks flagged
Higher coupon on new debt (7.875% vs 5.75%/5.375%) increases annual interest expense by approximately $15-18M
“New notes at 7.875% vs redeemed notes at 5.75% and 5.375%”
10 Mar 2026DEF 14ANet Sales $5.80B (+0% y/y); Net Loss $-386M; Adjusted EBITDA $742M (-3% y/y)open
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $5.80B | 0% y/y |
| Net Loss · FY2025 | $-386M | |
| Adjusted EBITDA · FY2025 | $742M | -3% y/y |
| Adjusted Net Income · FY2025 | $143M | |
| Operating Cash Flow · FY2025 | $264M | |
| Capital Expenditures · FY2025 | $213M | -41% y/y |
| TSS Net Sales · Thermal & Specialized Solutions · FY2025 | $2.10B | |
| TSS Adjusted EBITDA · Thermal & Specialized Solutions · FY2025 | $670M | +18% y/y |
| TT Net Sales · Titanium Technologies · FY2025 | $2.40B | -6% y/y |
| TT Adjusted EBITDA · Titanium Technologies · FY2025 | $145M | -52% y/y |
Risks flagged
PFAS Regulatory Risk
“The impacts of these various restrictions and regulatory measures in the EU as noted above, individually and in the aggregate, could lead to material adverse effects on our results of operations, financial condition, and cash flows.”
Litigation Liability Risk
“Litigation-related charges primarily includes $270 million related to the Company’s portion of Chemours, DuPont, Corteva, EID and the State of New Jersey’s settlement agreement reached in August 2025” · word for word
Environmental Remediation Cost Risk
“Environmental charges primarily includes changes in remediation reserves at the four sites covered by the New Jersey settlement agreement.” · word for word
26 Feb 20268-K · 8.01Principal amount of notes $700M; Coupon rate 7.875open
Figures in the filing · each found in the filing text
| Principal amount of notes · point_in_time | $700M | |
| Coupon rate · point_in_time | 7.9% |
Risks flagged
High coupon rate (7.875%) suggests elevated credit risk; increased leverage.
“7.875% coupon on $700M notes; upsized from $600M.”
24 Feb 202610-KGoodwill impairment charge $56Mopen
Figures in the filing · each found in the filing text
| Goodwill impairment charge · Advanced Performance Materials · FY2024 | $56M |
Risks flagged
PFAS litigation and regulatory liability
“The estimated liabilities of achieving the CO and Addendum objectives consist of several components, each of which may vary significantly and may exceed the recorded reserve estimates, which could be material.” · word for word
Tariff and trade disruption risk
“If significant tariffs or other restrictions continue to be placed on foreign imports by the United States and related countermeasures are taken by impacted foreign countries, our results of operations could be negatively affected.” · word for word
Operational disruption from weather/outages
“In June 2024, we had to temporarily pause production at our Altamira TiO 2 manufacturing facility in Mexico for approximately three weeks due to severe drought conditions.” · word for word
Internal control weaknesses (remediated)
“In 2023, we identified certain material weaknesses in our internal control over financial reporting, all of which were remediated in 2024.” · word for word
19 Feb 20268-K · 2.02Net Loss attributable to Chemours $-47M; Adjusted EBITDA $128M (-24% y/y); Full Year Net Sales $5.81B (+0% y/y); Guidance: Net sales growth 3-5%, Adjusted EBITDA $800-900M, FCF conversion >25%earningsopen
Figures in the filing · each found in the filing text
| Net Loss attributable to Chemours · Q4-2025 | $-47M | |
| Adjusted EBITDA · Q4-2025 | $128M | -24% y/y |
| Full Year Net Sales · FY2025 | $5.81B | 0% y/y |
| Full Year Net Loss attributable to Chemours · FY2025 | $-386M | |
| Full Year Adjusted EBITDA · FY2025 | $742M | -3% y/y |
Guidance
Net sales growth 3-5%, Adjusted EBITDA $800-900M, FCF conversion >25%
2026 guidance: modest revenue growth, EBITDA improvement from $742M to $800-900M, but below prior expectations.
Risks flagged
Cyclical end market headwinds in APM and TT; non-cash inventory charge.
“Short-term cyclical end market headwinds in APM; non-cash inventory charge and unfavorable product mix.”
16 Jan 20268-K · 1.01, 7.01Chemours entered agreements to sell former TiO2 site in Taiwan for ~$360M; proceeds to reduce debt. Non-core asset sale, not impairment but monetization of idle land.open
Figures in the filing · each found in the filing text
| total purchase price | $360M |
6 Nov 20258-K · 2.02Net Sales $1.50B (-1% y/y); Net Income attributable to Chemours $60M (+288% y/y); Adjusted EBITDA $195M (-3% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net Sales · total · Q3-2025 | $1.50B | -1% y/y |
| Net Income attributable to Chemours · total · Q3-2025 | $60M | +288% y/y |
| Adjusted EBITDA · total · Q3-2025 | $195M | -3% y/y |
| TSS Net Sales · Thermal & Specialized Solutions · Q3-2025 | $560M | +20% y/y |
| TSS Adjusted EBITDA · Thermal & Specialized Solutions · Q3-2025 | $194M | +40% y/y |
| TT Net Sales · Titanium Technologies · Q3-2025 | $612M | -9% y/y |
| TT Adjusted EBITDA · Titanium Technologies · Q3-2025 | $25M | -68% y/y |
| Opteon Refrigerants Net Sales · Thermal & Specialized Solutions · Q3-2025 | $368M | +80% y/y |
| Freon Refrigerants Net Sales · Thermal & Specialized Solutions · Q3-2025 | $94M | -36% y/y |
| EPS · total · Q3-2025 | $0.40 | +282% y/y |
Risks flagged
Operational disruptions at TT and APM segments impacting margins.
“TT segment Adjusted EBITDA decreased 68% due to operational disruptions; APM outage resolved but impacted volumes.”
Macroeconomic weakness in industrial end markets.
“demand weakness in industrial end markets” · word for word
6 Nov 202510-QChemours disclosed a $60M increase in environmental remediation reserves related to New Jersey PFAS settlement and ongoing regulatory risks.open
Risks flagged
PFAS regulatory risk
“The impacts of these various restrictions and regulatory measures in the EU as noted above, individually and in the aggregate, could lead to material adverse effects on our results of operations, financial condition, and cash flows.” · word for word
Environmental remediation liability risk
“in the second quarter of 2025, we recorded a $60 million increase to certain of our environmental and legal remediation reserves related to the sites covered by the settlement.” · word for word
Litigation risk
“In December 2024, the West Virginia Rivers Coalition filed a complaint under the Clean Water Act in West Virginia federal court alleging past and ongoing exceedances of certain effluent discharge limits” · word for word
31 Oct 20258-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
Potential cash liability if multiple executives are terminated without cause, but no immediate risk.
“Cash Severance Payment: CEO 2.0 times sum of base salary, target annual incentive opportunity and health care subsidy”
The Chemours Company — questions
- What did The Chemours Company file recently?
- 17 SEC filings in the last 12 months. Latest: 8-K on 2026-09-10 — Chemours, DuPont, and Corteva enter $455M settlement agreement with North Carolina and 11 local entities over PFAS emissions from Fayetteville Works facility. Payment over 15 years; Chemours responsible for 50%. Settlement resolves all PFAS
Every figure on this page comes from The Chemours Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.